Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_001148.6(ANK2):c.3571C>T(p.Arg1191Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000547 in 1,461,720 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
ANK2 (HGNC:493): (ankyrin 2) This gene encodes a member of the ankyrin family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton. Ankyrins play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. The protein encoded by this gene is required for targeting and stability of Na/Ca exchanger 1 in cardiomyocytes. Mutations in this gene cause long QT syndrome 4 and cardiac arrhythmia syndrome. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Dec 2011]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
p.Arg1191Trp (CGG>TGG):c.3571 C>T in exon 30 of the ANK2 gene (NM_001148.4). The Arg1191Trp variant in the ANK2 gene has not been reported as a disease-causing mutation or as a benign polymorphism to our knowledge. Arg1191Trp results in a non-conservative amino acid substitution of positively charged Arginine with a non-polar Tryptophan at a position that is conserved across species. In silico analysis predicts Arg1191Trp is is probably damaging to the protein structure/function. The NHLBI ESP Exome Variant Server reports Arg1191Trp was not observed in approximately 6,000 samples from individuals of European and African American backgrounds, indicating it is not a common benign variant in these populations. However, no mutations have been reported in this region of the ANK2 gene to date, indicating this region of the protein may tolerate change. In summary, the clinical significance of the Arg1191Trp variant in the ANK2 gene is currently unknown. The variant is found in LQT panel(s). -
Long QT syndrome Uncertain:1
May 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 1191 of the ANK2 protein (p.Arg1191Trp). This variant is present in population databases (rs771751897, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with ANK2-related conditions. ClinVar contains an entry for this variant (Variation ID: 190566). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ANK2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiac arrhythmia, ankyrin-B-related Uncertain:1
Jul 23, 2021
Fulgent Genetics, Fulgent Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter